Cavan John T 4
4 · ContraVir Pharmaceuticals, Inc. · Filed Jul 21, 2017
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Award
Stock Options
2017-07-20+15,000→ 133,688 totalExercise: $0.58Exp: 2027-07-20→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Options vest in three installments as follows: 5,000 vest on each of July 20, 2018, 2019 and 2020.